David Friedman, MD

Appointed
2008

Education & Fellowships

Fellowship - New York University Medical Center
Hand Surgery
New York, NY USA
1997

Residency - New York University Medical Center
Plastic Surgery
New York, NY USA
1996

Residency - University of Medicine and Dentistry of New Jersey - New Jersey Medical School
General Surgery
Newark, NJ USA
1994

Medical Education - University of Texas Southwestern Medical School
Dallas, TX USA
1988

Undergraduate - University of Texas at Austin
Austin, TX USA
1984

Additional Training

• General Surgery Research Fellow, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ

Professional Highlights

• Fellowship Director, Hand Surgery, New York University Medical Center
• Director, Multidisciplinary Hand and Upper Extremity Conference, NYU Medical Center
• Director, Hand and Uppeer Extremity Service, Bellevue Hospital Center, New York, NY

Certifications

• Hand Surgery
• Plastic Surgery

Specialty Interests

Fractures of the hand, hand and arm reconstruction, hand and upper extremity surgery, hand and wrist arthritis, hand related sports injuries, microsurgery of the hand and arm, nerve compressions of the hand, arm, and upper extremity, repetitive stress disorders of the hand and arm, wrist and distal radius

Awards & Honors

• Honorary Police Surgeon, New York City Police Department
• America's Top Doc, Castle and Connolley
• Susan B. Deak Excellence in Surgical Research Award
• First Prize, Clinical Paper, N. Y. Regional Society of Plastic and Reconstructive Surgery

Memberships

• American Society for Surgery of The Hand
• American Society of Plastic Surgeons
• American Association of Plastic Surgeons
• American College of Surgeons
• American Society of Peripheral Nerve

See publications for David Friedman, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/15/2019, Dr. Friedman has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Friedman receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

• Endo Pharmaceuticals, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.